Antheia Secures Additional $9M to Advance Domestic Pharma Supply Chains
Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, announced it has expanded the scope of its second project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), securing an additional $9 million. The additional fun…
